当前位置: X-MOL 学术N. Engl. J. Med. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma
The New England Journal of Medicine ( IF 158.5 ) Pub Date : 2021-08-19 , DOI: 10.1056/nejmoa2106391
Toni K. Choueiri 1 , Piotr Tomczak 1 , Se Hoon Park 1 , Balaji Venugopal 1 , Thomas Ferguson 1 , Yen-Hwa Chang 1 , Jaroslav Hajek 1 , Stefan N. Symeonides 1 , Jae Lyun Lee 1 , Naveed Sarwar 1 , Antoine Thiery-Vuillemin 1 , Marine Gross-Goupil 1 , Mauricio Mahave 1 , Naomi B. Haas 1 , Piotr Sawrycki 1 , Howard Gurney 1 , Christine Chevreau 1 , Bohuslav Melichar 1 , Evgeniy Kopyltsov 1 , Ajjai Alva 1 , John M. Burke 1 , Gurjyot Doshi 1 , Delphine Topart 1 , Stephane Oudard 1 , Hans Hammers 1 , Hiroshi Kitamura 1 , Jens Bedke 1 , Rodolfo F. Perini 1 , Pingye Zhang 1 , Kentaro Imai 1 , Jaqueline Willemann-Rogerio 1 , David I. Quinn 1 , Thomas Powles 1
Affiliation  

New England Journal of Medicine, Volume 385, Issue 8, Page 683-694, August 2021.


中文翻译:

肾细胞癌肾切除术后辅助派姆单抗

新英格兰医学杂志,第 385 卷,第 8 期,第 683-694 页,2021 年 8 月。
更新日期:2021-08-19
down
wechat
bug